Chief Executive Officer and Director

Chief Strategy Officer (CSO)

Fennec Pharmaceuticals Brief: Says Achieved Second Quarter 2025 Total Net Revenues of US$9.7 Million

Fennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business Update

Fennec Pharmaceuticals trading halted, volatility trading pause

Fennec Pharmaceuticals trading resumes

Oncology Strategic Account Manager

Fennec Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of PEDMARK®, aimed at reducing the risk of platinum-induced ototoxicity in pediatric patients. The Oncology Strategic Account Manager will be responsible for promoting PEDMARK® within their territory, building relationships with healthcare professionals, and educating them on the product's usage and efficacy.

Oncology Strategic Account Manager- New York

Strategic Account Manager, Oncology

Strategic Account Manager

Sign up with Google

Sign in with Google